TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.41 0.0 (1.21%) --- 0.0 (-0.19%) 0.0 (-0.19%) --- --- 0.0 (1.21%) 0.0 (1.21%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2124
Diluted P/E:
-0.2124
RSI(14) 1m:
40.96
VWAP:
0.41
RVol:
0.0114

Events

Period Kind Movement Occurred At
1m Price increase 1m 0.72 +0.01 (+2.0%) Oct 15 17:28
60m Price increase 60m 0.72 +0.04 (+5.69%) Oct 15 17:28
1m Price increase 1m 0.71 +0.06 (+9.9%) Oct 15 17:26
10m Price increase 10m 0.71 +0.07 (+10.06%) Oct 15 17:26
1m Price increase 1m 0.62 +0.01 (+1.71%) Oct 15 17:21

Related News